Orlando Park, FL, December 20, 2021 – The Now Corporation (OTC:NWPN), a bio-pharmaceutical research company focused on the research, education and production of Scientific-Grade Cannabidiol (CBD) from hemp and Tetrahydrocannabinol (THC), is pleased to announce that it has begun the process to apply for a patent with the United States Patent and Trademark Office for a novel cultivation platform. This will allow for the scientific growth of plants enriched with compounds with which to develop psychotropic medications to be used in research and medicine.
“The goal is to initiate a Holistic Research Program so as to bring awareness to the well-being of an individual being medically treated as a whole. Despite the lack of reputable scientific evidence from Holistic Medicine, The Now Corporation will scientifically re-record and preserve the effects of this ancient medicine and corresponding techniques” said The Now Corporation CEO, Ken Williams.
The specific emphasis will be on an aquatic plant that was grown in Northern Africa by the Ancient Egyptians and had significance in their religion. It had medicinal qualities ranging from being an aphrodisiac to pain management and depression. The Company expects to be the first to make its use widespread to the benefit of all of its stakeholders.
Updates will be forthcoming
The Now Corporation is a publicly traded, bio-pharmaceutical research company focused on the
research, education and production of Scientific-Grade Cannabidiol (CBD) from hemp and
Tetrahydrocannabinol (THC) to be used for medicinal purpose, while focusing on pursuing business
opportunities in the growing medical and recreational marijuana sector. Through its acquired assets, The Now Corporation is seeking to invest in our businesses associated with the growing, marketing, research and development, training, distribution and retail sale of scientific-grade medicinal cannabis, both in the United States and Canada. At The Now Corporation, we unlock and advance medicine for human life around the world, at every stage of life.
For further information, please contact:
Chief Executive Officer
The Now Corporation